Results 241 to 250 of about 195,293 (269)

Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia

Clinical and Experimental Nephrology, 2018
T. Wada, E. Muso, S. Maruyama, Akinori Hara, K. Furuichi, K. Yoshimura, M. Miyazaki, E. Sato, M. Abe, Y. Shibagaki, I. Narita, H. Yokoyama, Noriko Mori, Y. Yuzawa, T. Matsubara, T. Tsukamoto, J. Wada, Takafumi Ito, K. Masutani, K. Tsuruya, S. Fujimoto, A. Tsuda, H. Suzuki, K. Kasuno, Y. Terada, Takeshi Nakata, N. Iino, Shuzo Kobayashi   +27 more
semanticscholar   +1 more source

Preliminary Results from an International Registry on LDL-Apheresis in Children with Homozygous Hypercholesterolemia

Atherosclerosis Supplements, 2018
I. Luirink, E. Bruckert, E. Dann, S. Greber-Platzer, B. Hutten, D. Ibarretxe, J. Kastelein, L. Masana, M. Mäser, R. M. S. Hernández, C. Taylan, A. Wiegman, J. Groothoff   +12 more
semanticscholar   +1 more source

LDL Apheresis

2013
Huy P. Pham, Joseph Schwartz
openaire   +1 more source

[LDL-apheresis in Sardinia, Italy].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2012
A steady increase in mean serum cholesterol levels has been observed in the Sardinian population over the past three decades, probably related to modifications in the diet such as the introduction of fast food; however, the mean serum values are still lowest compared with the other Italian regions.
openaire   +1 more source

La LDL-aferesi:stato attuale. LDL-apheresis: current status

2001
PURPOSE: State of the art of LDL-apheresis and treatment of severe familiar hypercholesterolemia. PATIENTS AND METHODS: Clinical experience of treatment with LDL-apheresis of pediatric and adult patients with familial hypercholesterolemia using the following techniques: D.A.L.I., H.E.L.P., D.S.C.
STEFANUTTI, Claudia, Vivenzio A, Lucani G, Di Giacomo S.   +3 more
openaire   +1 more source

LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.

Journal of Clinical Lipidology, 2016
K. Lappegård, Terje Enebakk, Hilde Thunhaug, J. Ludviksen, T. Mollnes, A. Hovland   +5 more
semanticscholar   +1 more source

Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.

Atherosclerosis, 2016
K. Lappegård, Terje Enebakk, Hilde Thunhaug, A. Hovland   +3 more
semanticscholar   +1 more source

Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia.

Atherosclerosis, 2015
B. Lefort, S. Saheb, E. Bruckert, C. Giraud, O. Hequet, R. Hankard   +5 more
semanticscholar   +1 more source

LDL Apheresis

2015
Hedyeh Shafi, Holli M. Mason, Ellen Klapper   +2 more
openaire   +1 more source

Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.

Atherosclerosis Supplements, 2015
M. Bláha, M. Lánská, V. Bláha, L. Boudys, P. Žák   +4 more
semanticscholar   +1 more source